Opus Genetics to present OPGx-BEST1 Cohort 1 topline data
Topline Phase 1/2 Cohort 1 data from the OPGx-BEST1 gene therapy program will be presented on Sept. 9 at 8:00 a.m. ET in an investor webcast and conference call.
Topline data from Phase 1/2 Cohort 1 of OPGx-BEST1 gene therapy program to be presented during investor conference call and webcast on September 9 at 8:00 a.m.
ETFull clinical dataset and additional analyses evaluating key measures of visual function to be presented at upcoming medical meetingsRESE…